The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study
Clinical trial NCT05508633 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05508633
- Sponsor
- Shanghai Changzheng Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-28
- Primary completion
- 2025-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.